26 November 2021
Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful cancer research happening across departments, including Ludwig.
25 November 2021
A study from Professor Colin Goding’s group finds an unexpected mechanism controlling growth vs senescence in cancer.
11 November 2021
Interactions between transcription factors and the chromatin environment provide barriers controlling cell differentiation, according to research by Professor Yang Shi and colleagues.
19 October 2021
Dr Tammie Bishop’s and Professor Sir Peter Ratcliffe’s groups shed light on the developmental origins of inherited cancers with mutations in the HIF pathway.
8 October 2021
Ludwig Oxford is currently recruiting exceptional students for fully funded four-year NDM prize DPhil studentships commencing in October 2022.
1 October 2021
The University of Oxford is recruiting its third intake to study for a DPhil in Cancer Science commencing in October 2022.
1 October 2021
Our new Leadership Fellow launches a research group in cancer epigenetics and epitranscriptomics.
30 September 2021
Dr Benjamin Schuster-Böckler will join the Turing network for 2021-2022 to further his research in cancer big data.
21 September 2021
Ludwig Oxford welcomes Ellie Barnes to our community, which she has joined as a Ludwig Adjunct Scholar.
3 September 2021
A new publication from Benoit Van den Eynde's group has shown that a viral vector cancer vaccine generates effective anti-tumour immune responses and, in combination with immunotherapy, decreases tumour size and increases survival rates in mouse models.
9 August 2021
Claudia Zagami from the Boccellato lab was selected to give a talk on 3D tissue models for studying disease.
30 June 2021
Professor Stefan Constantinescu joins Ludwig Oxford to expand his research programme in cancer epigenetics.
9 June 2021
Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.
8 June 2021
Professor Yang Shi’s group demonstrates that combining drugs targeting epigenetic and metabolic pathways can overcome the arrest of white blood cell differentiation in this blood cancer.